Category

Company Updates

CR2O and Artemis Bioservices successfully continue their well-established cooperation

CR2O is a leading European clinical CRO, specialised in managing and operating early-stage infectious disease clinical trials. Artemis Bioservices is a specialty lab, evaluating viral vaccines and antiviral therapeutics, in...
Read More

CR2O and 3D-PharmXchange are celebrating and securing their successful ongoing collaboration

A successful drug development strategy is a well-designed and dynamic process. Making sure regulatory requirements are embedded from the start, is key. From pre-clinical all the way to registration, a...
Read More

CR2O profiled in Biotech NEWS and Life Sciences

Dutch industry magazine Biotech NEWS and Life Sciences has profiled CR2O in their 2020 Winter edition. Biotech NEWS and Life Sciences is a national magazine reporting on trends and news within health...
Read More

Update COVID-19: Safeguarding health and safety

As a result of the COVID-19 pandemic, CR2O has adapted its contingency plan aimed to guarantee the safety and well-being of patients, employees, clients and continuity of our services.By following...
Read More